Celiprolol pneumonitis.
We report on a patient who developed hypersensitivity pneumonitis during treatment with the beta-blocker, celiprolol. The clinical picture was a severe alveolitis, with compromised gas exchange. Inadvertent subsequent rechallenge with celiprolol led to recurrence of the pneumonitis, 10 weeks after drug readministration. Again, the pneumonitis was fully reversible. Lymphocytes were elevated in bronchoalveolar lavage, and progressively normalized upon discontinuation of the drug. This case is reminiscent of pneumonitis to other beta-blockers, which are reviewed here.
Lombard
J N
JN
Service de Pneumologie et de Réanimation Respiratoire, Centre Hospitalier Universitaire, Dijon, France.
Bonnotte
B
B
Maynadie
M
M
Foucher
P
P
Reybet Degat
O
O
Jeannin
L
L
Camus
P
P
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000542:Alveolitis, Extrinsic Allergic / Q000139:chemically induced* / Q000175:diagnosis; D017272:Celiprolol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D011859:Radiography
D000319:Adrenergic beta-Antagonists; D017272:Celiprolol